Lili Feng

2.4k total citations · 1 hit paper
58 papers, 1.9k citations indexed

About

Lili Feng is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lili Feng has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 18 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Lili Feng's work include Chronic Lymphocytic Leukemia Research (10 papers), Adenosine and Purinergic Signaling (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Lili Feng is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Adenosine and Purinergic Signaling (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Lili Feng collaborates with scholars based in China, United States and Japan. Lili Feng's co-authors include Xin Wang, Gabriela García, Mary E. Pauza, Ying Xia, Diana Lo, Constantin Makris, Randall S. Johnson, Thomas Schwarz, Jaclyn L. Roberts and Virginia Godfrey and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Lili Feng

57 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN

2024 55 citations Ying Xu, Lili Feng et al. Cancer Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lili Feng China	22	781	617	610	459	209	58	1.9k
Jin Ren United States	23	593 0.8×	791 1.3×	477 0.8×	246 0.5×	562 2.7×	45	1.9k
Laurent Gros France	24	564 0.7×	1.1k 1.8×	418 0.7×	171 0.4×	135 0.6×	59	2.3k
Emily F. Mason United States	12	1.2k 1.5×	833 1.4×	360 0.6×	519 1.1×	57 0.3×	32	2.3k
Paul E. Zarek United States	9	1.3k 1.6×	703 1.1×	419 0.7×	142 0.3×	374 1.8×	9	2.0k
Vanessa Byles United States	8	783 1.0×	1.3k 2.1×	237 0.4×	263 0.6×	111 0.5×	10	2.1k
Keiji Hirata Japan	28	268 0.3×	1.2k 1.9×	1.1k 1.8×	333 0.7×	113 0.5×	189	2.8k
C. Christian Johansson Sweden	19	940 1.2×	535 0.9×	590 1.0×	171 0.4×	38 0.2×	29	1.7k
Veela B. Mehta United States	18	360 0.5×	691 1.1×	224 0.4×	106 0.2×	128 0.6×	21	1.5k
Evan Burns United States	9	1.6k 2.0×	545 0.9×	290 0.5×	109 0.2×	87 0.4×	10	2.3k

Countries citing papers authored by Lili Feng

Since Specialization

Citations

This map shows the geographic impact of Lili Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Feng more than expected).

Fields of papers citing papers by Lili Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Feng. The network helps show where Lili Feng may publish in the future.

Co-authorship network of co-authors of Lili Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Feng. A scholar is included among the top collaborators of Lili Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Feng. Lili Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Ying, et al.. (2024). Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiology. 93. 102693–102693. 55 indexed citations breakdown →

Feng, Lili, et al.. (2023). Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia. Frontiers in Oncology. 13. 1244280–1244280. 5 indexed citations

Feng, Lili, et al.. (2022). In vitro Intervention of Lactobacillus paracasei N1115 Can Alter Fecal Microbiota and Their SCFAs Metabolism of Pregnant Women with Constipation and Diarrhea. Current Microbiology. 79(7). 212–212. 5 indexed citations

Feng, Lili, Xiaofang Xu, & Keke Zhao. (2021). NFYB potentiates STK33 activation to promote cisplatin resistance in diffuse large B-cell lymphoma. Leukemia Research. 111. 106708–106708. 11 indexed citations

Jiang, Yujie, et al.. (2020). Rituximab-induced acute thrombocytopenia in patients with splenomegaly B Cell lymphoma: an underdiagnosed but severe complication. Cancer Biology & Therapy. 21(11). 1060–1066. 3 indexed citations

Feng, Lili, Yiqing Cai, Mingchen Zhu, Lijie Xing, & Xin Wang. (2020). The yin and yang functions of extracellular ATP and adenosine in tumor immunity. Cancer Cell International. 20(1). 110–110. 68 indexed citations

Feng, Lili, Xiaoxia Chu, Hongguo Zhao, et al.. (2018). Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China. Blood. 132(Supplement 1). 2960–2960. 1 indexed citations

Cai, Yiqing, Lili Feng, Dai Yuan, Qian Wang, & Xin Wang. (2018). The Role of CD39/CD73/Ado/A2AR Axis and HIF-1α in Chronic Lymphocytic Leukemia. Blood. 132(Supplement 1). 4406–4406. 4 indexed citations

Lv, Xiao, Lili Feng, Xueling Ge, Kang Lu, & Xin Wang. (2016). Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma. Journal of Experimental & Clinical Cancer Research. 35(1). 106–106. 40 indexed citations

10.

Li, Peipei, Lili Feng, Na Chen, et al.. (2015). Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway. Medical Oncology. 32(2). 479–479. 20 indexed citations

11.

Lu, Kang, Xiaosheng Fang, Lili Feng, et al.. (2015). The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Letters. 359(2). 250–258. 23 indexed citations

12.

Shao, Lili, et al.. (2014). [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].. PubMed. 22(4). 920–6. 1 indexed citations

13.

Feng, Lili, et al.. (2011). IL-9 Contributes to Immunosuppression Mediated by Regulatory T Cells and Mast Cells in B-Cell Non-Hodgkin’s Lymphoma. Journal of Clinical Immunology. 31(6). 1084–1094. 55 indexed citations

14.

Feng, Lili & Xin Wang. (2010). Targeting Foxp3+ regulatory T cells-related immunosuppression for cancer immunotherapy.. PubMed. 123(22). 3334–42. 21 indexed citations

15.

Wan, Qin, Cheng Wang, Lili Feng, et al.. (2010). Regression to normoglycaemia by fenofibrate in pre‐diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial. Diabetic Medicine. 27(11). 1312–1317. 24 indexed citations

16.

Li, Quan‐Zhen, Ping Li, Gabriela García, Richard J. Johnson, & Lili Feng. (2005). Genomic Profiling of Neutrophil Transcripts in Asian Qigong Practitioners: A Pilot Study in Gene Regulation by Mind–Body Interaction. The Journal of Alternative and Complementary Medicine. 11(1). 29–39. 33 indexed citations

17.

Nishino, Michiya, Tuhina Mazumdar, Florence L. Lee, et al.. (2005). 16-kDa Prolactin Down-Regulates Inducible Nitric Oxide Synthase Expression through Inhibition of the Signal Transducer and Activator of Transcription 1/IFN Regulatory Factor-1 Pathway. Cancer Research. 65(17). 7984–7992. 28 indexed citations

18.

García, Gabriela, Sheng‐Xing Ma, & Lili Feng. (2005). Acupuncture and Kidney Disease. Advances in Chronic Kidney Disease. 12(3). 282–291. 16 indexed citations

19.

Jing, Naijie, Yidong Li, Xuejun Xu, et al.. (2003). Targeting Stat3 with G-Quartet Oligodeoxynucleotides in Human Cancer Cells. DNA and Cell Biology. 22(11). 685–696. 77 indexed citations

20.

Feng, Lili. (2001). Preliminary Supposes on Setting Up Digital Forestry System in Henan. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact